Stifel Financial Corp reduced its stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT - Free Report) by 14.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 504,414 shares of the company's stock after selling 87,140 shares during the quarter. Stifel Financial Corp owned about 0.47% of BlackRock Capital Allocation Term Trust worth $8,298,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of the stock. Ashton Thomas Securities LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the 3rd quarter valued at about $156,000. Walleye Capital LLC bought a new position in BlackRock Capital Allocation Term Trust in the third quarter valued at approximately $234,000. Truist Financial Corp acquired a new stake in BlackRock Capital Allocation Term Trust during the 2nd quarter worth $319,000. Prospera Financial Services Inc raised its position in shares of BlackRock Capital Allocation Term Trust by 5.0% during the 3rd quarter. Prospera Financial Services Inc now owns 23,693 shares of the company's stock valued at $390,000 after acquiring an additional 1,137 shares during the last quarter. Finally, Thrivent Financial for Lutherans acquired a new position in shares of BlackRock Capital Allocation Term Trust in the 3rd quarter valued at $398,000. Institutional investors own 36.12% of the company's stock.
In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. sold 14,973 shares of BlackRock Capital Allocation Term Trust stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $16.41, for a total transaction of $245,706.93. Following the transaction, the insider now directly owns 16,302,733 shares in the company, valued at approximately $267,527,848.53. The trade was a 0.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold a total of 723,927 shares of company stock valued at $11,925,047 in the last ninety days.
Shares of BlackRock Capital Allocation Term Trust stock opened at $16.32 on Friday. The business has a fifty day simple moving average of $16.20 and a 200 day simple moving average of $16.33. BlackRock Capital Allocation Term Trust has a 12 month low of $14.68 and a 12 month high of $17.18.
The business also recently announced a monthly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 16th will be given a dividend of $0.2892 per share. This is a positive change from BlackRock Capital Allocation Term Trust's previous monthly dividend of $0.10. This represents a $3.47 annualized dividend and a dividend yield of 21.26%. The ex-dividend date is Monday, December 16th.
-
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.
While BlackRock Capital Allocation Term Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.